Skip to main content
. 2022 Mar 29;23(5):166. doi: 10.3892/ol.2022.13286

Figure 6.

Figure 6.

Overall survival curves according to CD155 expression and PD-L1 expression. (Left) Comparison among all groups and (right) comparison between the CD155+/PD-L1+ group and others (CD155+/PD-L1, CD155-/PD-L1+ and CD155-/PD-L1). CD155, CD155 expression-negative; CD155+, CD155 expression-positive; PD-L1, programmed death-ligand 1; PD-L1, PD-L1 expression-negative; PD-L1+, PD-L1 expression-positive.